Literature Based Drug Interaction Prediction with Clinical Assessment Using Electronic Medical Records: Novel Myopathy Associated Drug Interactions
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Drug-drug interactions (DDIs) are a common cause of adverse drug events. In this paper, we combined a literature discovery approach with analysis of a large electronic medical record database method to predict and evaluate novel DDIs. We predicted an initial set of 13197 potential DDIs based on substrates and inhibitors of cytochrome P450 (CYP) metabolism enzymes identified from published in vitro pharmacology experiments. Using a clinical repository of over 800,000 patients, we narrowed this theoretical set of DDIs to 3670 drug pairs actually taken by patients. Finally, we sought to identify novel combinations that synergistically increased the risk of myopathy. Five pairs were identified with their p-values less than 1E-06: loratadine and simvastatin (relative risk or RR = 1.69); loratadine and alprazolam (RR = 1.86); loratadine and duloxetine (RR = 1.94); loratadine and ropinirole (RR = 3.21); and promethazine and tegaserod (RR = 3.00). When taken together, each drug pair showed a significantly increased risk of myopathy when compared to the expected additive myopathy risk from taking either of the drugs alone. Based on additional literature data on in vitro drug metabolism and inhibition potency, loratadine and simvastatin and tegaserod and promethazine were predicted to have a strong DDI through the CYP3A4 and CYP2D6 enzymes, respectively. This new translational biomedical informatics approach supports not only detection of new clinically significant DDI signals, but also evaluation of their potential molecular mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SLCO1B1 Variants and Statin-Induced Myopathy — A Genomewide Study
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801936 · Cited by 2,043 · cited 1×
“In a recent GWAS study, expression of the OATP1B1 transporter was shown to predict myopathy risk associated with simvastatin [20].”
BackgroundSystems Analysis of Adverse Drug Events
Leape, L. L. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530010049034 · Cited by 1,404
Stang, P. E., Ryan, P. B., Racoosin, J. A., Overhage, J. M., Hartzema, A. G., Reich, C., Welebob, E., Scarnecchia, T., & Woodcock, J. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-9-201011020-00010 · Cited by 441 · cited 1×
“These data have been anonymized and architected specifically for research on adverse drug reactions through collaboration with the Observational Medical Outcomes Partnership project [23].”
MethodSelf-citationTatonetti, N. P., Fernald, G. H., & Altman, R. B. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000214 · Cited by 203 · cited 2×
“A recent notable example in clinical pharmacology is the successful detection of novel DDIs through mining of the FDA’s Adverse Event Reporting System [10].”
Method
Cited by
Drug combination therapy increases successful drug repositioning
Sun, W., Sanderson, P. E., & Zheng, W. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.05.015 · Cited by 436
Cheng, F., & Zhao, Z. (2014) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2013-002512 · Cited by 374
Zhang, W., Chen, Y., Liu, F., Luo, F., Tian, G., & Li, X. (2017) · BMC Bioinformatics · doi:10.1186/s12859-016-1415-9 · Cited by 356
Self-citationNatural Language Processing for EHR-Based Pharmacovigilance: A Structured Review
Luo, Y., Thompson, W. K., Herr, T. M., Zeng, Z., Berendsen, M. A., Jonnalagadda, S. R., Carson, M. B., & Starren, J. (2017) · Drug Safety · doi:10.1007/s40264-017-0558-6 · Cited by 200
Development and evaluation of an ensemble resource linking medications to their indications
Wei, W.-Q., Cronin, R. M., Xu, H., Lasko, T. A., Bastarache, L., & Denny, J. C. (2013) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2012-001431 · Cited by 106
Systematic prediction of drug combinations based on clinical side-effects
Huang, H., Zhang, P., Qu, X. A., Sanseau, P., & Yang, L. (2014) · Scientific Reports · doi:10.1038/srep07160 · Cited by 73
Utilizing an integrated infrastructure for outcomes research: a systematic review
Dixon, B. E., Whipple, E. C., Lajiness, J. M., & Murray, M. D. (2016) · Health Information & Libraries Journal · doi:10.1111/hir.12127 · Cited by 27
Data mining for potential adverse drug–drug interactions
Hammann, F., & Drewe, J. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.894507 · Cited by 19
“[32] .”
Background
Metadata
- Authors
- Duke, J. D., Han, X., Wang, Z., Subhadarshini, A., Karnik, S. D., Li, X., Hall, S. D., Jin, Y., Callaghan, J. T., Overhage, M. J., Flockhart, D. A., Strother, R. M., Quinney, S. K., & Li, L.
- Venue
- PLoS Computational Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-08-09
- Volume
- 8
- Issue
- 8
- Pages
- e1002614
- ISSN
- 1553-734X (ISSN-L)
- 1553-7358
- OpenAlex
- W2029592334
- Cited by
- 128
- References
- 4
- FWCI
- 5.45
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.